$WORX

SCWorx Secures Waivers From Private Placement Investors, Preserving $938,000 Financing Amid Nasdaq Review

SCWorx (WORX) secured waivers from private placement investors, preserving $938,000 in financing. The waivers prevent investors from exercising termination rights due to a Nasdaq review, unless the stock is delisted or trading does not resume by October 31, 2026. This action helps maintain sufficient publicly held shares for continued Nasdaq listing.

Original reporting
Published Oct 5, 2026, 5:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 5:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SCWorx Secures Waivers From Private Placement Investors, Preserving $938,000 Financing Amid Nasdaq Review — source image
Decision brief

The 30-second read

$WORXNeutralLow
01

Why it matters

The waivers sustain the company's cash runway and share structure, reducing immediate delisting pressure.

02

Market read

A primary SEC filing that preserves financing for a Nasdaq‑listed micro‑cap, offering limited but concrete trading relevance.

03

What to watch

Potential future financing needs and the company's ability to meet Nasdaq's continued listing requirements beyond the waiver period.

Relevance 5/10Novelty 5/10Timing: effective Sep 29 2026

Background

SCWorx faced a Nasdaq Panel decision that could trigger delisting; the private placement investors held termination rights that could have withdrawn $938k of capital.

Company-level read

Ticker impact

$WORXNeutralMedium confidence
Context

SCWorx secured waivers from all private placement investors to preserve $938,000 financing and maintain Nasdaq listing.

Expected impact

modest support as market prices in the preserved financing and reduced delisting risk

Evidence & confidence

The filing is a primary disclosure but involves a small amount of capital for a micro‑cap, limiting the magnitude of price movement.

Market effects

Minimal impact on the broader technology or financing sector.

Limited to U.S. micro‑cap investors and Nasdaq compliance monitoring.

None

Counterpoint

The waiver may be seen as a temporary fix; investors could still price in potential delisting risk if Nasdaq reinstatement stalls.

Key entities

  • SCWorx Corp.

    Micro‑cap technology firm listed on Nasdaq under ticker WORX.

  • Nasdaq Panel

    Entity that issued the decision potentially affecting SCWorx's listing.

Related articles

$WORXHigh

SCWorx Announces Resumption of Nasdaq Trading and Highlights Improved Operating Performance and Growth Strategy

SCWorx Corp. (Nasdaq: WORX) resumed trading on Nasdaq after regaining compliance with listing requirements. The company reported improved operating performance, with Q2 2026 revenue of $706,000 and gross profit up 83% YoY. Net loss declined significantly, and cash usage decreased. SCWorx aims to grow its healthcare customer base and leverage AI for data management.

$WORXMed

SCWorx Corp. (WORX): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

SCWorx Corp. (WORX) filed an SEC Form 8-K — Other Events. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Summary Company Completed Offering to Cure Nasdaq Publicly Held Shares Deficiency and Submitted Request for Reconsideration; Common Stock Continues to Be Quoted on OTCQB

Med

SCWorx Corp.: SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company's Continued Listing on the Nasdaq Capital Market

SCWorx Corp. said Nasdaq’s Hearings Panel issued a partial compliance letter confirming completion of the first benchmark in its approved plan to regain compliance for continued listing. The remaining requirement is to meet the Nasdaq minimum bid price of at least $1.00 for 20 consecutive trading days, under Listing Rule 5815(c)(4).